Is single point HbA1c a reliable predictor for death in severe COVID-19?


HbA1c, Death, COVID-19, Predictor


The severity of COVID-19 infection is affected by several risk factors such as Diabetes Mellitus (DM). The current study aimed to determine the effect of single-point HbA1c on the severity and mortality of hospitalized COVID-19 patients.


This cross-sectional study was conducted among hospitalized moderate and severe COVID-19 patients in Baharloo Hospital in Iran between   December 23rd and February 23rd, 2021. The patients have been diagnosed by Polymerase Chain Reaction (PCR) and Chest Computed Tomography (CT) imaging as COVID -19. Demographic data, clinical presentation, laboratory results, and treatments along with the HbA1C data were included.


165 COVID-19 cases were included in this study; 126 (76.4%) of which were severe cases. 89 (53.9%) patients were male, with a mean age of 59.89± 16.59 years. Severe COVID-19 patients were more prone to a longer hospital stay, and a higher level of inflammatory mediators, compared to the moderate COVID-19 patients (P<0.05). No significant association was found between single point HbA1C, FBS, and severity and mortality of COVID- cases (p>0.05).


 Single point HbA1c was not a reliable mediator for the prediction of severity or death in hospitalized COVID-19 patients.


Coronavirus disease (COVID-19) []

Alkundi A, Mahmoud I, Musa A, Naveed S, Alshawwaf M: Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single centre study. Diabetes Research and Clinical Practice 2020, 165:108263.

Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Al-Omari A, Dhawan M: Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines 2021, 9(5):436.

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DS: Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine 2020, 382(18):1708-1720.

Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y: Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine 2020, 180(7):934-943.

Chung SM, Ahn JH, Moon JS: Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (Diabetes Metab J 2020; 44: 405–13). Diabetes & metabolism journal 2020, 44(4):625-626.

Zhu L, She Z-G, Cheng X, Qin J-J, Zhang X-J, Cai J, Lei F, Wang H, Xie J, Wang W: Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell metabolism 2020, 31(6):1068-1077. e1063.

Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I: Diabetes mellitus, fasting glucose, and risk of cause-specific death. The New England journal of medicine 2011, 364(9):829-841.

McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ: The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes care 2005, 28(4):810-815.

Casqueiro J, Casqueiro J, Alves C: Infections in patients with diabetes mellitus: A review of pathogenesis. Indian journal of endocrinology and metabolism 2012, 16(Suppl1):S27.

Wang B, Glicksberg BS, Nadkarni GN, Vashishth D: Evaluation and management of COVID-19-related severity in people with type 2 diabetes. BMJ Open Diabetes Research and Care 2021, 9(1):e002299.

Sayit AT, Elmali M, Deveci A, Gedikli O: Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia. Revista do Instituto de Medicina Tropical de São Paulo 2021, 63.

Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, Xu J, Wu F, Duan L, Yin Z et al: Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia 2020, 63(10):2102-2111.

Diabetes []

Hu T, Liu Y, Zhao M, Zhuang Q, Xu L, He Q: A comparison of covid-19, sars and mers. PeerJ 2020, 8:e9725.

Vidal-Cevallos P, Higuera-De-La-Tijera F, Chávez-Tapia NC, Sanchez-Giron F, Cerda-Reyes E, Rosales-Salyano VH, Servin-Caamaño A, Vazquez-Medina MU, Méndez-Sánchez N: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study. Annals of Hepatology 2021, 24:100338.

Nathan DM, Group DER: The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes care 2014, 37(1):9-16.

Wang B, Glicksberg BS, Nadkarni GN, Vashishth D: Evaluation and management of COVID-19-related severity in people with type 2 diabetes. BMJ Open Diabetes Res Care 2021, 9(1).

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S: Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of infection 2020, 81(2):e16-e25.

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P: Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020, 584(7821):430-436.

Yang J, Feng Y, Yuan M, Yuan S, Fu H, Wu B, Sun G, Yang G, Zhang X, Wang L: Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabetic medicine 2006, 23(6):623-628.

Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A: Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC public health 2020, 20(1):1-9.

Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS: Practical recommendations for the management of diabetes in patients with COVID-19. The lancet Diabetes & endocrinology 2020, 8(6):546-550.

Ardigo D, Valtuena S, Zavaroni I, Baroni MC, Delsignore R: Pulmonary complications in diabetes mellitus: the role of glycemic control. Current Drug Targets-Inflammation & Allergy 2004, 3(4):455-458.

Hayek S, Ben‐Shlomo Y, Balicer R, Byrne K, Katz M, Kepten E, Raz I, Roitman E, Zychma M, Barda N: Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID‐19: A retrospective, cohort study. Diabetes, obesity & metabolism 2021.

Kulcsar KA, Coleman CM, Beck SE, Frieman MB: Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI insight 2019, 4(20).

Koh H, Moh AMC, Yeoh E, Lin Y, Low SKM, Ooi ST, Tan SK, Lin JHX, Hoong CWS: Diabetes predicts severity of COVID‐19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C‐reactive protein. Journal of medical virology 2021, 93(5):3023-3032.

Agarwal S, Schechter C, Southern W, Crandall JP, Tomer Y: Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019. Diabetes Care 2020, 43(10):2339-2344.

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia 2020, 63(8):1500-1515.

Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, Liu C, Xiong M, Deng A, Zhang Y: Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes care 2020, 43(7):1399-1407.

Moutschen M, Scheen A, Lefebvre P: Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete & metabolisme 1992, 18(3):187-201.